Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution
出版年份 2018 全文链接
标题
Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution
作者
关键词
-
出版物
Immunotherapy
Volume 10, Issue 8, Pages 713-728
出版商
Future Medicine Ltd
发表日期
2018-03-23
DOI
10.2217/imt-2017-0178
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Subcutaneous Immunoglobulin Therapy for Hypogammaglobulinemia Secondary to Malignancy or Related Drug Therapy
- (2017) Tanja M. Windegger et al. TRANSFUSION MEDICINE REVIEWS
- Use of Rituximab in Systemic Lupus Erythematosus: A Single Center Experience Over 14 Years
- (2017) R. Aguiar et al. ARTHRITIS CARE & RESEARCH
- Pragmatic Treatment of Patients With Systemic Lupus Erythematosus With Rituximab: Long-Term Effects on Serum Immunoglobulins
- (2017) Venkat Reddy et al. ARTHRITIS CARE & RESEARCH
- Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist
- (2016) David A. Khan ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
- (2016) Emilio Besada BMC MUSCULOSKELETAL DISORDERS
- Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
- (2016) Til Menge et al. Expert Review of Neurotherapeutics
- NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation
- (2016) Heidrun Boztug et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Incidence of Profound Hypogammaglobulinemia and Infection Rate in Lymphoma Patients Following the Combination of Chemotherapy and Rituximab
- (2016) Kalman Filanovsky et al. Recent Patents on Anti-Cancer Drug Discovery
- Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
- (2016) Til Menge et al. Expert Review of Neurotherapeutics
- Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions
- (2015) Md Yuzaiful Md Yusof et al. ANNALS OF THE RHEUMATIC DISEASES
- Regulatory B Cells: Origin, Phenotype, and Function
- (2015) Elizabeth C. Rosser et al. IMMUNITY
- The expanding family of regulatory B cells
- (2015) Claudia Mauri et al. INTERNATIONAL IMMUNOLOGY
- Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab—for how long?
- (2015) Sara Barmettler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Practice parameter for the diagnosis and management of primary immunodeficiency
- (2015) Francisco A. Bonilla et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
- (2015) Darren M. Roberts et al. JOURNAL OF AUTOIMMUNITY
- Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series
- (2015) Darren M. Roberts et al. JOURNAL OF AUTOIMMUNITY
- Longterm Safety of Rituximab: Final Report of the Rheumatoid Arthritis Global Clinical Trial Program over 11 Years
- (2015) R. F. van Vollenhoven et al. JOURNAL OF RHEUMATOLOGY
- Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: A retrospective cohort study
- (2015) Federico De Angelis et al. LEUKEMIA RESEARCH
- Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study
- (2014) Mathias Witzens-Harig et al. ANNALS OF HEMATOLOGY
- Profound symptomatic hypogammaglobulinemia: A rare late complication after rituximab treatment for immune thrombocytopenia. Report of 3 cases and systematic review of the literature.
- (2014) Romain Levy et al. AUTOIMMUNITY REVIEWS
- The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease
- (2014) Helena Marco et al. BMC MUSCULOSKELETAL DISORDERS
- Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients
- (2014) N. Compagno et al. HAEMATOLOGICA
- Rituximab
- (2014) Ulrich Storz mAbs
- Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study
- (2014) P. S. Sorensen et al. NEUROLOGY
- Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement
- (2014) Sai S. Duraisingham et al. PLoS One
- Hypogammaglobulinaemia after rituximab treatment--incidence and outcomes
- (2014) M. Makatsori et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
- (2014) Federico Alberici et al. RHEUMATOLOGY
- Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis
- (2014) Emilio Besada et al. RHEUMATOLOGY
- Rituximab and Immune Deficiency: Case Series and Review of the Literature
- (2014) Blanka Kaplan et al. Journal of Allergy and Clinical Immunology-In Practice
- A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function
- (2013) E. G. Kamburova et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Off-label use of rituximab in dermatology: pemphigus treatment
- (2013) Lislaine Bomm et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Safety and efficacy of90Yttrium-Ibritumomab-Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study
- (2013) Adalberto Ibatici et al. BRITISH JOURNAL OF HAEMATOLOGY
- Complicated pathophysiology behind rituximab-induced persistent hypogammaglobulinemia
- (2013) Gen Kano et al. IMMUNOLOGY LETTERS
- Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models
- (2013) S. Herter et al. MOLECULAR CANCER THERAPEUTICS
- Low- Versus High-Dose Rituximab for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Markus Bredemeier et al. ARTHRITIS CARE & RESEARCH
- Ofatumumab, the first human anti-CD20 monoclonal antibody for the treatment of B cell hematologic malignancies
- (2012) Ira V. Gupta et al. Annals of the New York Academy of Sciences
- Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections
- (2012) Carla Casulo et al. Clinical Lymphoma Myeloma & Leukemia
- Rituximab-Treated Patients Have a Poor Response to Influenza Vaccination
- (2012) Robert A. Eisenberg et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Use of Combination Chemotherapy for Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in Patients with Common Variable Immunodeficiency (CVID)
- (2012) Nicole M. Chase et al. JOURNAL OF CLINICAL IMMUNOLOGY
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
- (2012) Matthieu Mahévas et al. JOURNAL OF CLINICAL INVESTIGATION
- Does rituximab induce hypogammaglobulinemia in patients with pediatric idiopathic nephrotic syndrome?
- (2012) Laëtitia Delbe-Bertin et al. PEDIATRIC NEPHROLOGY
- Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides
- (2012) Nils Venhoff et al. PLoS One
- Targeting B Cells and Antibody in Transplantation
- (2011) M. R. Clatworthy AMERICAN JOURNAL OF TRANSPLANTATION
- A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
- (2011) S. De Vita et al. ARTHRITIS AND RHEUMATISM
- The future of anti-CD20 monoclonal antibodies: are we making progress?
- (2011) W. Alduaij et al. BLOOD
- Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
- (2011) S. Audia et al. BLOOD
- Rituximab therapy for Type I membranoproliferative glomerulonephritis
- (2011) John J. Dillon et al. CLINICAL NEPHROLOGY
- Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
- (2011) Ludwig Kappos et al. LANCET
- Rituximab Therapy in Idiopathic Membranous Nephropathy: A 2-Year Study
- (2010) F. C. Fervenza et al. Clinical Journal of the American Society of Nephrology
- Deciphering antibody-mediated rejection: new insights into mechanisms and treatment
- (2010) Mark D Stegall et al. Current Opinion in Organ Transplantation
- Human peripheral blood B-cell compartments: A crossroad in B-cell traffic
- (2010) M. Perez-Andres et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- (2010) Erika Irie et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- B cells as therapeutic targets in SLE
- (2010) Iñaki Sanz et al. Nature Reviews Rheumatology
- Rituximab in Severe Pemphigus
- (2009) Enno Schmidt et al. Annals of the New York Academy of Sciences
- Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: A long-term followup study of thirty-two patients
- (2009) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Good and bad memories following rituximab therapy
- (2009) E. William St.Clair ARTHRITIS AND RHEUMATISM
- Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
- (2009) Clifton O. Bingham et al. ARTHRITIS AND RHEUMATISM
- Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin
- (2009) Nichola Cooper et al. BRITISH JOURNAL OF HAEMATOLOGY
- PERSISTENT ANTIBODY DEPLETION AFTER RITUXIMAB IN THREE CHILDREN WITH AUTOIMMUNE CYTOPENIAS
- (2009) Mehdi Mohammad G. Adeli et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Improvement in patient-reported outcomes in a rituximab trial in patients with severe rheumatoid arthritis refractory to anti–tumor necrosis factor therapy
- (2008) E. Keystone et al. ARTHRITIS AND RHEUMATISM
- Anti-CD20 therapy in patients with rheumatoid arthritis: Predictors of response and B cell subset regeneration after repeated treatment
- (2008) Petra Roll et al. ARTHRITIS AND RHEUMATISM
- Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis
- (2008) Shouvik Dass et al. ARTHRITIS AND RHEUMATISM
- Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study
- (2008) B. Godeau et al. BLOOD
- Delay in B-lymphocyte recovery and function following rituximab for EBV-associated lymphoproliferative disease early post-allogeneic hematopoietic SCT
- (2008) K Masjosthusmann et al. BONE MARROW TRANSPLANTATION
- Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma
- (2008) L K Hicks et al. BONE MARROW TRANSPLANTATION
- Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma
- (2008) Alison R. Walker et al. CANCER INVESTIGATION
- A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery
- (2008) Jennifer A. Sutter et al. CLINICAL IMMUNOLOGY
- Rituximab: Beyond Simple B Cell Depletion
- (2008) A. Kessel et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin’s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation
- (2008) Mitsufumi Nishio et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation
- (2008) Ashley A. Vo et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started